ation of single bone marrow progenitors into macroscopic colonies of macrophages (Stanley et al., 1978) . M-CSF Binding of macrophage colony stimulating factor also stimulates survival and proliferation of mature mono-(M-CSF) to its receptor (Fms) induces dimerization cytes and macrophages and enhances their differentiated and activation of the tyrosine kinase domain of the functions (Stanley, 1981; Tushinski et al., 1982) . The key receptor, resulting in autophosphorylation of cytorole of M-CSF in mononuclear phagocyte development plasmic tyrosine residues used as docking sites for has been demonstrated in vivo with osteopetrotic (op/op) SH2-containing signaling proteins that relay growth mutant mice that lack functional M-CSF and are deficient and development signals. To determine whether a in osteoclasts and macrophages. Both cell types are distinct signaling pathway is responsible for the Fms presumably derived from a common progenitor (Wiktordifferentiation signal versus the growth signal, we Jedrzejczak et al., 1990) and the op/op defects can sought new molecules involved in Fms signaling by be cured by injection of M-CSF (Wiktor-Jedrzejczak performing a two-hybrid screen in yeast using the et al., 1991) . autophosphorylated cytoplasmic domain of the wildAll biological effects of M-CSF are mediated through type Fms receptor as bait. Clones containing SH2 a single high affinity receptor expressed on the cell surface domains of phospholipase C-γ2 (PLC-γ2) were freof monocytes, macrophages and their progenitors (Byrne quently isolated and shown to interact with phosphoryl et al., 1981) and encoded by the proto-oncogene c-fms ated Tyr721 of the Fms receptor, which is also the (Sherr et al., 1985; Woolford et al., 1985) . The protein binding site of the p85 subunit of phosphatidylinositol product, Fms, is a member of a class of growth factor 3-kinase (PI3-kinase). At variance with previous receptor tyrosine kinases (RTKs) that include the α and reports, M-CSF induced rapid and transient tyrosine β platelet-derived growth factor (PDGF) receptors, Kit, a phosphorylation of PLC-γ2 in myeloid FDC-P1 cells receptor of the stem cell factor and the Flt3/FLK2 receptor and this activation required the activity of the PI3- (Rosnet and Birnbaum, 1993) . These transmembrane kinase pathway. The Fms Y721F mutation strongly receptors transduce extracellular ligand messages into decreased this activation. Moreover, the Fms Y807F intracellular signals via pathways controlling cell survival, mutation decreased both binding and phosphorylation apoptosis, proliferation and differentiation, depending on of PLC-γ2 but not that of p85. Since the Fms Y807F cellular context (Ullrich and Schlessinger, 1990) . Their mutation abrogates the differentiation signal when common mechanism of activation is initiated by ligand expressed in FDC-P1 cells and since this phenotype binding that enables receptor dimerization, activation of the could be reproduced by a specific inhibitor of PLC-γ,
Introduction
when activated and we are interested in how these signals are integrated, transmitted and interpreted for the cellular Hematopoiesis is a developmental process in which totioutput response. The process begins with at least five potent bone marrow stem cells generate eight different tyrosine (Y) autophosphorylation sites in the cytoplasmic blood cell lineages necessary for constant replacement of domain. Y559 in the juxtamembrane region is a binding senescent mature cells or to respond to a stress, like site for Src family members when phosphorylated (Alonso hemorrhage or infection (Metcalf, 1989) . This implies precise regulation of the balance between cell growth, et al., 1995). Three sites, Y697, Y706 and Y721, are located in the kinase insert (KI) region that splits the functional tyrosine kinase domain of the receptor. Phosphorylated Y697 binds the SH2 domain of the Grb2 adaptor molecule, which is constituitively associated with the nucleotide exchange factor mSOS. Translocation of the Grb2-mSOS complex from the cytoplasm to the plasma membrane is sufficient for Ras activation (van der Geer and Hunter, 1993; Lioubin et al., 1994) . Phosphorylated Y706 binds the STAT1 transcription factor (Novak et al., 1996) and phosphorylated Y721 binds the p85 subunit of phosphatidylinositol 3-kinase (PI3 kinase) (Reedijk et al., 1992) . Another autophosphorylation site, Y807, is located in the second half of the kinase domain (Tapley et al., 1990) and corresponds to an autophosphorylation site conserved among most of the tyrosine kinases (Hanks and Quinn, 1991) . Based on structural analysis of other RTKs, this latter tyrosine could act as a regulatory site rather than a direct binding site (Hubbard et al., 1994) , however, the Y807 site in v-Fms has recently been implicated in p120Ras GAP binding (Trouliaris et al., 1995) . One of our principal interests is defining the mechanisms that control signaling pathways for growth, survival and differentiation. Do the existing pathways described above each regulate one or more biological functions of the receptor or do additional, as yet undefined, signaling pathways participate? To address these possibilities, a two-hybrid screen was initiated to look for additional signaling proteins interacting with activated Fms. The results identified several new interacting proteins and their analysis will be reported elsewhere (R.P.Bourette, G.M.Myles and L.R.Rohrschneider, in preparation). In addition, the SH2 domains of phospholipaseC-γ2 (PLC- (Downing et al., 1989) . domain of the wild-type murine Fms protein ( Figure  1A ). This construct was transformed into Saccharomyces cerevisiae L40 and expression of the bait fusion protein phosphorylation when expressed as a fusion protein with the LexA DNA binding domain, as previously shown with examined by immunoprecipitation and Western blotting. Yeast lysates were immunoprecipitated with antibodies to the insulin receptor (O'Neill et al., 1994) . Autophosphorylation also occurred at expected tyrosine residues (see the cytoplasmic domain of Fms and Western blotting with anti-LexA, anti-Fms or anti-phosphotyrosine antibodies below), suggesting that LexA-Fms autophosphorylation accurately recapitulated this activation step. demonstrated that a tyrosine-phosphorylated fusion protein of the size expected for the LexA-Fms construct (~75 kDa) A VP16 target library containing cDNA from the pluripotent hematopoietic EML cell line  was produced ( Figure 1B) . The tyrosine phosphorylation of this bait protein in yeast demonstrates that the receptor Lioubin et al., 1996) was used to screen for clones encoding Fms-interacting proteins. EML cells expressing cytoplasmic domain retains the ability to undergo auto-the wild-type murine Fms from a retroviral vector exhibit both proliferation and differentiation in response to M-CSF stimulation (R.P.Bourette, L.R.Rohrschneider and S. Tsai, unpublished data) . This suggests that the EML VP16 cDNA library should contain most of the cytoplasmic substrates necessary for these two Fms signaling pathways.
A stable LexA-Fms-expressing L40 yeast clone was transformed with the EML VP16 cDNA library and between 10 and 20ϫ10 6 transformants were screened, resulting in 166 clones positive for transcriptional activation of the his3 and lacZ reporter genes. Using VP16 sense and antisense primers (Vojtek and Hollenberg, 1995) , sequences of the interacting EML VP16 clones were determined and compared with existing cDNA sequence databases. The vast majority of the clones obtained contained SH2 domains, including the SH2 domains of the known Fms partners, Grb2, p85 and Fyn. New SH2-containing proteins were identified and some non-SH2-containing proteins were cloned. In addition, we also obtained multiple clones that contained one (N-or C-terminal) or both SH2 domains of PLC-γ2 ( Figure 1C ). PLC-γ was not believed to interact with Fms or to be activated by Fms (Downing et al., 1989) yet we obtained multiple clones of each SH2 domain. The potential relev- (K614A) Fms to check for tyrosine kinase dependence of the interaction. Different single autophosphorylation site Fms mutations were used to determine the exact site of the N-SH2 domain of PLC-γ2. In contrast, the clones containing the C-SH2 domain (EML131) or both the Ninteraction and an Fms mutant with five known autophosphorylation sites mutated to phenylalanines (5F) was and C-SH2 domains (EML110) of PLC-γ2 reacted with all Tyr→Phe mutants examined. Because the interaction included as a general check for specificity. Both SH2 domains of the p85 subunit of PI3-kinase were fused to with Fms was still tyrosine kinase dependent (i.e. negative on the KD mutant), these results indicate that the C-SH2 VP16 as a positive control and shown to interact, as expected (Reedijk et al., 1992) , with the tyrosine phosdomain of PLC-γ2 is interacting with a tyrosine-phosphorylated site on Fms either non-specifically and/or with phorylated Y721 site (Figure 2, lower right panel) . This demonstrated the specificity of the system and accurate one not examined in this study. autophosphorylation of the Y721 site. The Grb2 SH2 domain also demonstrated appropriate binding specificity
The PLC-γ2 SH2 domains interact cooperatively with activated Fms in vitro for the phosphorylated Y697 site (data not shown).
PLC-γ2 SH2 domain clones, as VP16 fusions, were To confirm the interaction between PLC-γ2 SH2 domains and the Fms receptor, we constructed GST fusion proteins each retested against the panel of negative, positive and mutant LexA-Fms baits described above. In the mating containing either N-, C-or N-and C-SH2 domains of murine PLC-γ2. As a control, similar fusion proteins with experiment, no interactions were detected with LexA alone or with the LexA-kinase-dead (KD) Fms (Figure 2) , the SH2 domains of the p85 subunit of PI3-kinase were constructed. FDC-P1 cells expressing wild-type murine indicating that the interactions between the LexA-wildtype Fms bait and the PLC-γ2 SH2 domain clones (fused to Fms (FD/wtFms) (Bourette et al., 1995) were starved of growth factor and either unstimulated or stimulated with VP16) were dependent on the presence of the cytoplasmic domain of Fms and its tyrosine kinase activity. The EML M-CSF (1 min at 37°C). Cell lysates were mixed with the different GST fusion proteins coupled to glutathioneclone (EML101) containing only the N-SH2 domain of PLC-γ2 did not interact with either the LexA-Fms mutant Sepharose beads. Tyrosine-phosphorylated proteins binding strongly to the GST-SH2 domain fusion proteins were Y721F or the LexA-Fms 5F mutant ( Figure 2 ), suggesting that phosphorylated residue Y721 is the binding site for analyzed by Western blotting with an anti-phosphotyrosine Synergistic binding of SH2 domains to receptors has been previously reported for p85 (Reedijk et al., 1992) , PLC-γ1 and GAP (Anderson et al., 1990 ). These results demonstrate that SH2 domains of PLC-γ2 interact in vitro with intact M-CSF-activated Fms, confirming the observation made with the two-hybrid system. The interaction of PLC-γ2 SH2 domains with activated Fms, however, was much lower than that detected in the two-hybrid yeast system and required the presence of both SH2 domains. This is probably due to the fact that the two-hybrid system is much more sensitive than immunoprecipitation in detecting protein-protein interactions.
PLC-γ2 is rapidly and transiently tyrosine phosphorylated in response to M-CSF in vivo
To determine whether PLC-γ2 was tyrosine phosphorylated in response to M-CSF, starved FD/wtFms cells were stimulated at 37°C with M-CSF and cell lysates were prepared at times up to 10 min after stimulation. PLC-γ2 and p85 were immunoprecipitated from each lysate and the extent of tyrosine phosphorylation of each protein determined by Western blotting ( Figure 4A ). A PLC-γ2 tyrosine-phosphorylated band of 150 kDa was detected after 5 s stimulation. The extent of tyrosine phosphorylation reached a maximum after 30 s with a broad plateau to 2 min and complete disappearance after 3 min M-CSF stimulation. Tyrosine phosphorylation of p85 after M-CSF stimulation ( Figure 4A ) also occurred rapidly (within 5 s), but remained high for a longer period than observed for PLC-γ2. Tyrosine-phosphorylated p85 was still detected and dephosphorylated and/or degraded 3 min later. As previously described (Varticovski et al., 1989) , p85 is also tyrosine phosphorylated in response to M-CSF, but the antibody ( Figure 3A ). Under these conditions activated tyrosine-phosphorylated form persists for a longer period Fms could be detected as a 165 kDa phosphoprotein. of time. Significant Fms association was not observed with single
The effect of a phosphotyrosine phosphatase inhibitor PLC-γ2 N-or C-SH2 domains, but when both PLC-γ2 (Na 3 VO 4 ) on the extent and duration of PLC-γ2 tyrosine SH2 domains in tandem were fused to the GST protein, phosphorylation was examined. FD/wtFms cells were a detectable amount of Fms receptor was precipitated incubated for 15 min with a phosphatase inhibitor prior from the M-CSF-stimulated cells ( Figure 3A ). In contrast, to M-CSF stimulation and transient tyrosine phosphoryleither the N-or C-SH2 domain alone of the p85 protein ation of PLC-γ2 was measured as above ( Figure 4B ). An associated with Fms after M-CSF stimulation. Interaction increase in the duration of PLC-γ2 phosphorylation was of Fms with the N-SH2 domain was much weaker than seen (from 3 to 5 min) with an elevated peak of tyrosine interaction with the C-SH2 domain. When both N-and phosphorylation at 3 min. This suggests that endogenous C-SH2 domains of p85 were fused to GST, a very large tyrosine phosphatases are indeed implicated in the decrease amount of M-CSF-stimulated Fms was observed. To in PLC-γ2 phosphorylation after M-CSF stimulation. Tyroensure that the precipitated 165 kDa phosphoprotein was sine phosphatases have been shown to be activated by really Fms and not another tyrosine kinase receptor of the Fms (Yi and Ihle, 1993 ; Carlberg and Rohrschneider, same size we performed a precipitation experiment using 1997) and could participate in down-regulation of PLCa GST-PLCγ2 (N-and C-)SH2 domain fusion, detecting γ2. Alternatively, we cannot rule out the possibility that a precipitated Fms receptor with a polyclonal anti-Fms minor fraction of PLC-γ2 is proteolytically degraded. antibody ( Figure 3B ). Fms receptor was detected in precipitates only when the GST fusion protein was mixed The Y721F and Y807F Fms mutations strongly with lysate of M-CSF-stimulated cells ( Figure 3B ). Condecrease tyrosine phosphorylation of PLC-γ2 in sistent with the data in Figure 3A , this experiment demon-
FDC-P1 cells strates that PLCγ2 (N-and C-)SH2 domains bind to
The association of p85 with the phosphorylated Fms Y721 site is known (Reedijk et al., 1992) and we next sought activated Fms receptor in vitro. Immunoprecipitates were run on a 7% polyacrylamide gel, blotted and probed with anti-phosphotyrosine antibody (αPY) or antibodies to PLC-γ2 or p85. (B) As above, but starved FD/wtFms cells were incubated at 37°C in the presence of 2 mM Na 3 VO 4 before (15 min) and during M-CSF stimulation. Cell lysates were immunoprecipitated with anti-PLC-γ2 antibody and Western blots probed sequentially with antiphosphotyrosine (αPY) and anti-PLC-γ2 (αPLC-γ2) antibodies. a similar genetic link between phosphorylation of PLCWe next investigated the effects of other Fms autophosphorylation site mutants on PLC-γ2 tyrosine phosphoryl-γ2 and the tyrosine-phosphorylated Fms 721 site. The FmsY721F mutant receptor was introduced into FDC-P1 ation. No effect of Y559F, Y697F or Y706F mutations could be detected on PLC-γ2 or p85 tyrosine phosphorylcells and in vivo tyrosine phosphorylation of PLC-γ2 and p85 was examined 1 min after M-CSF stimulation and ation (not shown). In contrast, the FmsY807F mutant dramatically and selectively affected tyrosine phosphorylcompared with that seen in FD/wtFms cells ( Figure 5A ). The Y721F mutation abolished p85 tyrosine phosphorylation of PLC-γ2. Almost no detectable tyrosine-phosphorylated PLC-γ2 was observed after stimulation of FD/ ation as previously described (Reedijk et al., 1992) and mature tyrosine-phosphorylated 165 kDa FmsY721F proFmsY807F cells compared with FD/wtFms cells ( Figure  6A ). This effect was reproduced when PLC-γ2 was tein did not associate with p85. The SH2 domains of p85, however, still associate with a tyrosine-phosphorylated immunoprecipitated from FD/FmsY807F cells at various times after M-CSF stimulation and phosphotyrosine con-100 kDa protein, as we have previously shown (Carlberg and Rohrschneider, 1997) . Immunoprecipitation of PLCtent detected by Western blotting ( Figure 6B ). Again, little or no tyrosine phosphorylation of PLC-γ2 was detectable. γ2 from FD/wtFms cells revealed a single 150 kDa tyrosine-phosphorylated band after M-CSF stimulation Binding of p85 to Fms in M-CSF-stimulated cells was high regardless of whether wild-type-or Y807F mutantand mutation of the Y721 autophosphorylation site resulted in a significant decrease in PLC-γ2 tyrosine phosphoryltransfected cells were examined (Figure 6 bottom). The Y807F mutation also had no effect on M-CSF-dependent ation ( Figure 5B) . A time course study of M-CSF stimulation of FD/FmsY721F cells confirmed that the strong tyrosine phosphorylation of p85 (not shown). Interestingly, as we have noted elsewhere (K.Carlberg and L.R. decrease in PLC-γ2 tyrosine phosphorylation was not due to a delay in the response to M-CSF ( Figure 5C ).
Rohrschneider, manuscript in preparation), a significant amount of p85 was bound to the unstimulated FmsY807F A phosphorylated band of approximately the size of PLC-γ2 was visible on the p85 immunoprecipitate of FD/ mutant receptor ( Figure 6C ). The ability of both SH2 domains from PLC-γ2 or p85 wtFms and this blot was stripped and reprobed with anti-PLC-γ2 antibody. PLC-γ2 was not detectable, suggesting to bind either the wild-type, Y721F or Y807F Fms receptors was tested by measuring the ability of GST-SH2 that PLC-γ2 did not co-immunoprecipitate with p85 (not shown). Although not the most sensitive assay, the results fusion proteins to immunoprecipitate Fms. The content of tyrosine-phosphorylated proteins in lysates of control suggest that PLC-γ2 and p85 do not simultaneously bind to the same Fms molecule.
uninfected cells, wild-type, Y721F or Y807F FD/Fms binding of the PLC-γ2 SH2 domains to Y721F Fms is consistent with the two-hybrid data, showing that the N-SH2 domain is specific for the Y721 site, whereas the cells stimulated with M-CSF was examined with antiphosphotyrosine blots ( Figure 7A ). As we have shown C-SH2 domain is promiscuous. Compared with the Y721F mutant, binding of both PLC-γ2 SH2 domains to the before (Carlberg et al., 1991; Bourette et al., 1995) , the extent of Fms tyrosine autophosphorylation is not Y807F mutant Fms was higher, but it was still less than that seen with wild-type Fms. As a control we used a dramatically different among the wild-type and mutant receptors, but the Y721F mutant was slightly lower in GST-Grb2 SH2 domain fusion protein, since Grb2 binds to phosphotyrosine 697 and its association with Fms is this experiment. The interaction of p85 SH2 domains with activated Fms was eliminated by the Y721F mutation, not altered by Y721F or Y807F mutations (van der Geer and Hunter, 1993; Lioubin et al., 1994) . Thus it was whereas the Y807F mutation had no effect on p85 SH2 domain binding. This result is consistent with previous expected that this fusion protein would bind equally to wild-type, Y721F and Y807F Fms proteins. As shown in PLC-γ2 tyrosine phosphorylation is regulated by the activity of PI3-kinase Figure 7D , binding of Y721F and Y807F Fms mutants with the fusion protein were only slightly affected com-
The data indicate that two enzymes, sharing a common substrate (phosphatidylinositol 4,5-bisphosphate), both pared with wild-type Fms. Accordingly, this demonstrates that low phosphotyrosine levels in Fms precipitates bind to the same tyrosine-phosphorylated site on Fms. We therefore examined potential regulatory mechanisms for obtained after interaction of Y721F and Y807F Fms with GST-PLCγ2 SH2 ( Figure 7C ) could not be simply their mutually exclusive binding. We determined whether the enzymatic activity of PI3-kinase was necessary for explained by a reduced phosphotyrosine content per receptor (due to the single tyrosine mutation).
tyrosine phosphorylation of PLC-γ2 in M-CSF-stimulated cells. Wortmannin, a relatively specific inhibitor of PI3-These results indicate that both SH2 domains of p85 and the N-SH2 domain of PLC-γ2 specifically bind to the kinase activity (Ui et al., 1995; Wymann et al., 1996) , was used to treat FD/wtFms cells at 37°C for 30 min phosphorylated Y721 site and demonstrate that the lack of PLC-γ2 tyrosine phosphorylation by Fms mutant Y807F before M-CSF stimulation and tyrosine phosphorylation of PLC-γ2 was examined by immunoprecipitation and is not merely due a loss of the PLC-γ2 binding site. blotting ( Figure 8A ). Almost no tyrosine-phosphorylated shown previously (Bourette et al., 1995) . When the PLC-γ2 could be detected following wortmannin incubinhibitor was present in the M-CSF grown cultures no ation. On a gross scale, the effect appeared to be specific such decrease in the rate of M-CSF-dependent proliferation to PLC-γ2 because tyrosine-phosphorylated proteins in was observed and the cells exhibited exponential growth, total cell lysates did not change after treatment with as observed in cultures grown in the presence of IL-3 wortmannin ( Figure 8B ). Tyrosine phosphorylation of ( Figure 9B ). These results suggest that PLC-γ2 activity is immunoprecipitated Shc also did not change with wortconnected with the growth inhibition (and differentiation) mannin treatment. In separate experiments, no significant occurring in FD/wtFms cells stimulated with M-CSF change in tyrosine phosphorylation of p85 could be (Bourette et al., 1995) . detected and no significant modulation of p85 bound to
The M-CSF-dependent macrophage differentiation of Fms was detectable (not shown). These results suggest FD/wtFms cells was also monitored by morphological that the activity of PI3-kinase is required for tyrosine criteria in the presence or absence of the PLC-γ inhibitor phosphorylation and activation of PLC-γ2 by the Fms (U73122). The results in Figure 9C -E demonstrate the receptor. morphology of cells grown under various conditions and stained with May-Grünwald/Giemsa. FD/wtFms cells PLC-γ2 activity is required for differentiation of maintained in the presence of IL-3 had an immature M-CSF-stimulated FD/wtFms cells myeloid cell morphology with a large nucleus and a The potential role of PLC-γ2 in the biological effects of basophilic cytoplasm. These cells resembled parental FDC-M-CSF was tested by treating FD/wtFms cells with the P1 cells and did not change morphology in the presence PLC-γ (both 1 and 2 isotypes) inhibitor U73122 (Chen of U73122 ( Figure 9C ). Morphological differentiation was et al., 1996) before M-CSF stimulation. Cell proliferation apparent in FD/wtFms cells grown with M-CSF for 3 days in liquid cultures with or without U73122 (0.1 μM) was without inhibitor (Figure 9D ), as previously demonstrated measured in the presence of either 5% WCM, as a source (Bourette et al., 1995) . In the presence of the inhibitor, of IL-3, or with 2500 U/ml M-CSF. The presence of however, M-CSF grown cells failed to demonstrate a the PLC-γ inhibitor had no effect on IL-3-dependent major morphological change ( Figure 9E ). Instead, most exponential proliferation of FD/wtFms cells ( Figure 9A) . cells resembled those grown in IL-3, with a minority When FD/wtFms cells were cultivated in the presence of acquiring monocytic morphology. These results indicate M-CSF but in the absence of the inhibitor the growth rate that PLC-γ activation is involved in the M-CSF-dependent was lower than in the presence of IL-3 and gradually pathway for signaling terminal differentiation of FD/ decreased over the 6 day period. This is due to terminal macrophage differentiation in the population, as we have wtFms cells along the macrophage lineage. 
Discussion
Thus the LexA fusion protein with the Fms domain in yeast appeared to recapitulate the initial autophosphorylation The two-hybrid system was used to isolate proteins process characterized in mammalian cells. interacting with the cytoplasmic domain of the murine Fms/M-CSF receptor (Fields and Song, 1989; Chien et al., PLC-γ2 is a substrate of the Fms/M-CSF receptor 1991; Vojtek et al., 1993; Fields and Sternglanz, 1994;  and binds to phosphorylated Y721 Kikuchi et al., 1994; O'Neill et al., 1994; Wang,T. et al., The yeast two-hybrid screen identified several PLC-γ2 1994; Lioubin et al., 1996) . A LexA-Fms fusion protein, cDNA clones interacting with tyrosine-phosphorylated containing the entire cytoplasmic tyrosine kinase domain Fms (Figure 1 and data not shown). In all cases the PLCof wild-type murine Fms protein, was expressed as a bait. γ2 clones encompassed one or both of the SH2 domains. Because the LexA portion of the fusion protein binds to
The N-SH2 domain exhibited absolute specificity for the DNA as a dimer, it is assumed that co-dimerization and phosphorylated Fms site Y721, whereas the C-SH2 domain transphosphorylation of the attached Fms tyrosine kinase bound equally well to phosphorylated wild-type and domain is facilitated, as previously proposed for the insulin Y721F Fms, indicating a much more promiscuous interreceptor tyrosine kinase domain (O'Neill et al., 1994) .
action. Neither N-nor C-SH2 domains bound to KD Fms. This is analogous to the c-Met receptor, whose activation This same specificity for binding activated Fms at the results from substitution of a dimerization motif for the phosphorylated Y721 site was demonstrated by immunoextracellular and transmembrane domains (Rodrigues and precipitation experiments utilizing the PLC-γ2 SH2 Park, 1993). Introduction of the LexA-Fms construct into domains fused to GST and by tyrosine phosphorylation yeast resulted in expression of the fusion protein and and activation (Nishibe et al., 1990) of PLC-γ2 in M-CSFtyrosine autophosphorylation on three known sites (Y559, stimulated FD/wtFms cells. Activation of PLC-γ2 was Y697 and Y721), as judged by the fact that molecules greatly decreased in M-CSF-stimulated FD/FmsY721F known to bind these phosphorylated sites were isolated cells. Therefore, we proposed that PLC-γ2 interacts with during the library screen. In addition, mutation of the Fms the phosphorylated Y721 site on activated Fms and is Y807 site, although not a known binding site for signaling tyrosine phosphorylated in the process. However, we could proteins, exhibited identical properties in the yeast system not detect any significant association of Fms receptor and as the LexA fusion protein compared with expression of the full-length mutant protein in FDC-P1 cells (see below).
PLC-γ2 in vivo by co-immunoprecipitation (data not shown). This could reflect the transient activation of PLCbinding of either PLC-γ1 or the p85 subunit of PI3-kinase (Larose et al., 1993) . Clearly, binding of PLC-γ2 and p85 γ2 and competition with p85 for binding to phosphotyrosine 721 (see below). On the other hand, hepatocyte to a single tyrosine-phosphorylated site is a possibility. However, based on our results with the GST-SH2 domain growth factor/scatter factor (HGF/SF) receptor was shown to induce tyrosine phosphorylation of PLC-γ in two fusions (Figure 3) , the affinity for Fms appears to be much higher with p85 SH2 domains than with PLC-γ2 SH2 different cell lines, expressing 5000 and 100 000 receptors/ cell respectively, but complexes of PLC-γ and receptors domains. The yeast mating data and the immunoprecipitations could be detected only in the latter cell line (Ponzetto et al., 1994) . Since FD/wtFms cells express~5000 receptors/cell with the GST-SH2 fusion proteins (Figures 2 and 3) indicated that both SH2 domains of p85 were specific for (Novak et al., 1996) , complexes of Fms receptor and PLC-γ2 in FD/wtFms cells might be below the limit of the phosphorylated Y721 site of Fms. In contrast, only the N-SH2 domain of PLC-γ2 bound to the Y721 site, but detection by a co-immunoprecipitation experiment.
Stimulation by multiple tyrosine kinase receptors, the C-SH2 domain bound equally well to wild-type Fms or to Fms containing five mutated known sites of tyrosine including receptors for PDGF, epidermal growth factor, nerve growth factor, fibroblast growth factor, Kit and the autophosphorylation. This suggests that an as yet unknown autophosphorylation site may bind the C-SH2 domain of insulin receptor, all induce increased phosphorylation and activation of PLC-γ (Noh et al., 1995) . Even though Fms PLC-γ2. The C-SH2 domain of PLC-γ2 may anchor the protein to Fms allowing the N-SH2 domain to exchange shares structural features with some of these growth factor receptors, several reports have indicated that Fms does with the p85 SH2 domain(s) under appropriate conditions. A similar situation has been described for the PDGF not bind nor activate PLC-γ (Whetton et al., 1986; Downing et al., 1989; Hartmann et al., 1990) . There are receptor, where the C-SH2 domain of GAP specifies binding to Y771, the C-SH2 domain of p85 binds to either several possible explanations for the discrepancies between our present results and previous failures to detect PLC-γ Y740 or Y751 and each N-SH2 domain of the proteins binds to unidentified phosphorylation sites (Cooper and activation by Fms. Many of the previous studies were done on PLC-γ1, which may give different results than Kashishian, 1993) . The experiments with the PI3-kinase inhibitor wortman-PLC-γ2. Also, we show here that PLC-γ2 is rapidly phosphorylated and dephosphorylated after M-CSF stimunin demonstrated that PI3-kinase activity was required for activation of PLC-γ2. This suggests, perhaps, that some lation (see Figure 4 ) and after 5 min, when measurements were previously made (Downing et al., 1989) , our results product in the PI3-kinase pathway may negatively influence binding of p85 to phosphorylated Y721 and/or indicate that PLC-γ2 is already dephosphorylated. Another possibility is that PLC-γ2 activation by Fms is cell positively affect PLC-γ2 binding to the same site. If the N-SH2 domain of PLC-γ2 exchanges with the p85 SH2 type specific. Fms may not activate PLC-γ2 in mature macrophages (Whetton et al., 1986; Downing et al., 1989) domains for binding to the phosphorylated Y721 site on activated Fms, how does this occur if the affinity of p85 and human Fms may not function properly in hamster fibroblasts (Hartmann et al., 1990 ). This may not be for Fms is much higher? One possibility is that a feedback mechanism removes the higher affinity binder (p85), surprising because two examples of myeloid-specific interactions of Fms have already been reported (Lioubin et al., allowing the lower affinity molecule (PLC-γ2) to bind. Phosphatidylinositol 3,4,5-trisphosphate (PtdIns[3,4,5]P 3 ) 1994 , 1996 Carlberg and Rohrschneider, 1997) .
is the lipid product of PI3-kinase acting on the substrate phosphatidylinositol 4,5-bisphosphate. PtdIns[3,4,5]P 3 has p85/PI3-kinase and PLC-γ2 compete for binding to the Fms Y721 site been shown to bind to the SH2 domains of p85 (Rameh et al., 1995) and, as a product in the PI3-kinase pathway, The phosphorylated Y721 of the Fms receptor is a known binding site for the p85 subunit of PI3-kinase (Reedijk would be a logical molecule decreasing p85 binding at the Fms Y721 site and permitting the N-SH2 domain of et al., 1992), suggesting that PLC-γ2 and p85 may compete for binding to the same site. Both could occupy the same PLC-γ2 to occupy this site. We also investigated possible negative feedback along Y721 site on different subunits of the dimer receptor, however, we feel this is unlikely because we have not the PLC-γ2 pathway. Treatment of FD/wtFms cells with the specific PLC-γ inhibitor U73122 before and during detected PLC-γ2 in immunoprecipitates of p85 bound to M-CSF-stimulated Fms. Two signaling molecules sharing M-CSF stimulation had no effect on tyrosine phosphorylation of PLC-γ2 (not shown), suggesting that the products a common phosphotyrosine-containing site has been reported for the PDGF receptor, where Nck and p85 both of PLC-γ2 enzymatic activation do not feed back to influence PLC-γ2 binding to Fms. Therefore, alternative bind to phosphorylated Y751 (Nishimura et al., 1993) , and for the HGF/SF receptor (Ponzetto et al., 1994) . The mechanisms, such as phosphorylation or dephosphorylation of PLC-γ2, could influence its association with Fms, recognition sequence of the Fms receptor that binds p85 SH2 domains is YVEM (Songyang et al., 1993) , but the and this will require further investigation. recognition sequence for the PLC-γ2 SH2 domains has not yet been described and it is difficult to extrapolate Relationship between differentiation and activation of both of PLC-γ2 and PI3-kinase by the from the known binding motif of PLC-γ1 SH2 domains because the amino acid homology between the respective
Fms receptor
The Fms autophosphorylation site Y807 is located in the SH2 domains of PLC-γ1 and PLC-γ2 is~60% (Emori et al., 1989; Koch et al., 1991) . Interestingly, substitution second half of the kinase domain (Tapley et al., 1990) and corresponds to an autophosphorylation site conserved of amino acids surrounding Tyr1021 on the PDGF receptor, which binds only PLC-γ1, creates a site accommodating among most tyrosine kinases (Hanks and Quinn, 1991) .
It is presently uncertain whether this site interacts with can be found on our laboratory Web page (http:// www.fhcrc.org/~lrr). specific SH2-containing signaling proteins or whether signal transduction is changed by an altered protein It is not clear whether such a mechanism alone regulates differentiation signaling, but the U73122 inhibitor and conformation induced by phosphorylation at this site (Hubbard et al., 1994) . In favor of the first hypothesis, Y807F mutant studies effectively block PLC-γ2 activation, indicating that PLCγ activity is required for differentiation, Tyr807 of the v-Fms oncogene product has been described as a possible binding site of p120Ras GAP in fibroblasts although, as noted above, other signaling proteins may also participate. Surprisingly, however, mutation of Fms (Trouliaris et al., 1995) , however, direct evidence that GAP binds to this site is lacking. Alternatively, interaction Tyr721 has only a minor effect on differentiation signaling in FDC-P1 cells (Bourette et al., 1995) . This suggests that of Fms with GAP could occur through a conformational change in the Fms kinase domain as a result of tyrosine the PLC-γ2 activated through Y721 may have only a minor role in differentiation signaling or accounts for only phosphorylation at Y807. Other proteins also bind to M-CSF-stimulated Fms in a Y807-dependent manner.
a portion of the mechanism. However, the Fms Y721F mutant could simply represent a 'leaky' mutation, because Association of Src-like proteins with the human Fms receptor occurs at Tyr561 (559 of the murine receptor) some PLC-γ2 is still tyrosine phosphorylated in the mutanttransfected cells ( Figure 5 ). Alternatively, other Fms (Alonso et al., 1995) , but mutation of Tyr809 (807 of the murine receptor) reduces binding (Courtneidge et al., signaling molecules, such as Cbl and Src-like proteins, also may contribute to PI3-kinase and PLC-γ activation 1993). Using Fms receptor mutants and phosphopeptides, it was shown that the STAT1 binding site on the murine (Hartley et al., 1995; Lee and Rhee, 1995; Takata and Kurosaki, 1996) . Redundant neuronal differentiation Fms receptor is Tyr706, but both Y706F and Y807F mutations abrogate M-CSF-dependent STAT1 activation signaling through the Trk receptor has been described (Obermeier et al., 1994; Stephens et al., 1994) and Fms in FDC-P1 cells (Novak et al., 1996) . Based on our data and the literature, we suggest that tyrosine phosphorylation may also utilize multiple signals for myeloid differentiation. of FmsY807 controls the conformation of the receptor and its differential interaction with signaling molecules.
The opposing effects of PI3-kinase and PLC-γ2 reported in the literature are consistent with our proposed mechanLack of phosphorylation at the Fms Y807 (i.e. FmsY807F) site would result in decreased binding of Src family ism for Fms signaling. The role of PI3-kinase in the mechanism of cell transformation and mitogenic signaling members, the STAT1 transcription factor and PLC-γ2 (Bishayee et al., 1988; Keating et al., 1988) .
has been extensively documented (for a review see Carpenter and Cantley, 1996) . In contrast, PLC-γ has We have previously shown that M-CSF-induced differentiation of FD/wtFms cells toward macrophages was been described as a negative feedback regulator of the proliferation signal transduced by tyrosine kinase receptors eliminated by the single Y807F mutation (Bourette et al., 1995) . Proliferation of the cells was not decreased by the (Kerr et al., 1996; Obermeier et al., 1996) and neurite outgrowth can be blocked by inhibitors of PLC-γ (Kimura Y807F mutation, but rather increased, consistent with elimination of terminal differentiation. The effects on Fms et al., 1994; Hall et al., 1996) . Moreover, several studies have recently elucidated the role of protein kinase C signaling of the specific inhibitor of PLC-γ U73122 are very similar to those observed with the Y807F mutation (PKC) family members in monocytic differentiation (Mischak et al., 1993; Whetton et al., 1994; Kiley and (Figure 9) , suggesting that the lack of differentiation observed with the Y807F mutation was due to its inability Parker, 1995; Rossi et al., 1996) . PKC is a downstream element of the PLC-γ pathway and therefore regulated to activate the PLC-γ pathway. Wortmannin, a specific inhibitor of PI3-kinase activity, also prevented PLC-γ activation of PLC-γ2 by Fms is a critical component of the monocyte/macrophage differentiation pathway. activation. Together, these data suggest a complex mechanism for regulating cellular differentiation by controlling reciprocal activation of PI3-kinase and PLC-γ. We propose that upon M-CSF dimerization and activation of Fms
Materials and methods one conformation of the autophosphorylated cytoplasmic
Yeast two-hybrid system tyrosine kinase domain binds signal transduction proteins Plasmids, S.cerevisiae strains, selective media and the transformation including p85/PI3-kinase at the phosphorylated Y721 site.
protocol have been described previously (Vojtek and Hollenberg, 1995) .
Subsequent trans-autophosphorylation of Fms at the Y807
His3 reporter gene after 3 days growth on medium lacking uracil, techniques of Western transfer to nitrocellulose and immunoblotting tryptophan, leucine, lysine and histidine (WHULK) and containing have been described previously (Carlberg and Rohrschneider, 1994; 50 mM 3-amino-1,2,4-triazole (Sigma). Purified DNA isolated from Bourette et al., 1995) . positive clones was sequenced by PCR using VP16-specific sense and antisense primers (Vojtek and Hollenberg, 1995) . Sequence comparisons Morphological studies were done with the Genetics Computer Group (GCG) programs and Cells were cytocentrifuged onto glass slides, air dried, stained with different DNA sequence databases using the FASTA program. Mating May-Grünwald/Giemsa stain (Sigma) and mounted in Permount (Fisher). assay experiments were performed as previously described (Vojtek and Hollenberg, 1995) and interactions between the new bait and the protein of the VP16 library were visualized by spotting cells on WHULK plates containing X-Gal to detect transactivation of the β-galactosidase reporter for the EML VP16 cDNA library, Andrew Berger for expert technical Cells and culture conditions assistance with flow cytometry analysis, Ruth White for secretarial FDC-P1 clone 19 cells and derivatives expressing wild-type or mutant assistance, all the members of L.Rohrschneider's laboratory, Fms have been described previously (Bourette et al., 1995) . These cells R.Eisenmam's laboratory and J.Cooper's laboratory for generous gifts were maintained in Dulbecco's modified Eagle's medium (DMEM) of reagents and helpful discussions, especially Paul Algate, Kristen supplemented with 10% fetal bovine serum (FBS) and murine interleukin Carlberg, Carol Laherty, Mario Lioubin, Christophe Quéva, Anne Vojtek, 3 (IL-3) from conditioned medium of WEHI cells (WCM) or X63-IL-3 cells (Karasuyama and Melchers, 1988) . For culture with M-CSF, cells Sue Geier and Ingrid Wolf. This work was supported by a fellowship were washed and resuspended in DMEM, 10% FBS supplemented from the Leukemia Research Foundation (R.P.B.) and PHS grants with 2500 U/ml recombinant murine M-CSF partially purified from a CA20551 and CA40987 from the National Cancer Institute. conditioned medium from Sf9 insect cells expressing M-CSF from a baculovirus vector (Wang et al., 1993) . Uncoupling of the proliferation and differentiation signals mediated by antiserum to the murine Shc SH2 domain was raised to the GST fusion the murine macrophage colony-stimulating factor receptor expressed in protein (Lioubin et al., 1996) . PLC-γ-specific inhibitor U73122 was myeloid FDC-P1 cells. Cell Growth Differ., 6, 631-645. from BIOMOL and the PI3-kinase-specific inhibitor wortmannin was Byrne,P.V., Guilbert,L.J. and Stanley,E.R. (1981) Distribution of cells from Sigma.
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